Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease
Bernard De Bruyne, Nico H.J. Pijls, Bindu Kalesan, Emanuele Barbato, Pim A.L. Tonino, Zsolt Piróth +4 more
New England Journal of Medicine
Abstract
BACKGROUND: The preferred initial treatment for patients with stable coronary artery disease is the best available medical therapy. We hypothesized that in patients with functionally significant stenoses, as determined by measurement of fractional flow reserve (FFR), percutaneous coronary intervention (PCI) plus the best available medical therapy would be superior to the best available medical therapy alone. METHODS: In patients with stable coronary artery disease for whom PCI was being considered, we assessed all stenoses by measuring FFR. Patients in whom at least one stenosis was functionally significant (FFR, ≤0.80) were randomly assigned to FFR-guided PCI plus the best available medical therapy (PCI group) or the best available medical therapy alone (medical-therapy group). Patients i